FDA Breakthrough Therapy designation for Rituxan in pemphigus vulgaris – The Pharma Letter (registration)

FDA Breakthrough Therapy designation for Rituxan in pemphigus vulgaris – The Pharma Letter (registration)

FDA Breakthrough Therapy designation for Rituxan in pemphigus vulgaris – The Pharma Letter (registration)
Published on 2017-03-27